Search research articles
Contact Us
Filters
Showing results (101-110 of 114) with videos related to
Page
of 12
Sort By:
Blood
|
May 16, 2000
Treatment outcome in infant acute lymphoblastic leukemia. Children Leukemia Cooperative Group--EORTC. European Organization for Research and Treatment of Cancer
A Ferster, Y Benoit, N Francotte, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|
May 26, 2021
CNS-3 status remains an independent adverse prognosis factor in children with acute lymphoblastic leukemia (ALL) treated without cranial irradiation: Results of EORTC Children Leukemia Group study 58951
N Sirvent, S Suciu, B De Moerloose, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1997
Systemic effect of intrathecal methotrexate during the initial phase of treatment of childhood acute lymphoblastic leukemia. The European Organization for Research and Treatment of Cancer Children's Leukemia Cooperative Group
A Thyss, S Suciu, Y Bertrand, et al.
Leukemia
|
September 2, 2005
Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group report
N Entz-Werle, S Suciu, J van der Werff ten Bosch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 3, 2001
Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial
F Millot, S Suciu, N Philippe, et al.
Leukemia
|
March 4, 2005
Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG
J van der Werff Ten Bosch, S Suciu, A Thyss, et al.
Annals of the Rheumatic Diseases
|
September 14, 2004
Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity
I M De Kleer, D M C Brinkman, A Ferster, et al.
Leukemia
|
September 16, 2015
Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol
E M C Driessen, P de Lorenzo, M Campbell, et al.
Leukemia
|
December 7, 2017
Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol
E M C Driessen, P de Lorenzo, M Campbell, et al.
Leukemia
|
September 26, 2013
An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions
E Clappier, M F Auclerc, J Rapion, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 114) with videos related to
Sort By:
Page
of 12
Blood
|
May 16, 2000
Treatment outcome in infant acute lymphoblastic leukemia. Children Leukemia Cooperative Group--EORTC. European Organization for Research and Treatment of Cancer
A Ferster, Y Benoit, N Francotte, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|
May 26, 2021
CNS-3 status remains an independent adverse prognosis factor in children with acute lymphoblastic leukemia (ALL) treated without cranial irradiation: Results of EORTC Children Leukemia Group study 58951
N Sirvent, S Suciu, B De Moerloose, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1997
Systemic effect of intrathecal methotrexate during the initial phase of treatment of childhood acute lymphoblastic leukemia. The European Organization for Research and Treatment of Cancer Children's Leukemia Cooperative Group
A Thyss, S Suciu, Y Bertrand, et al.
Leukemia
|
September 2, 2005
Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group report
N Entz-Werle, S Suciu, J van der Werff ten Bosch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 3, 2001
Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial
F Millot, S Suciu, N Philippe, et al.
Leukemia
|
March 4, 2005
Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG
J van der Werff Ten Bosch, S Suciu, A Thyss, et al.
Annals of the Rheumatic Diseases
|
September 14, 2004
Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity
I M De Kleer, D M C Brinkman, A Ferster, et al.
Leukemia
|
September 16, 2015
Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol
E M C Driessen, P de Lorenzo, M Campbell, et al.
Leukemia
|
December 7, 2017
Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol
E M C Driessen, P de Lorenzo, M Campbell, et al.
Leukemia
|
September 26, 2013
An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions
E Clappier, M F Auclerc, J Rapion, et al.
Page
of 12